175 related articles for article (PubMed ID: 34605437)
1. Structural characterization of human peptidyl-arginine deiminase type III by X-ray crystallography.
Rechiche O; Lee TV; Lott JS
Acta Crystallogr F Struct Biol Commun; 2021 Oct; 77(Pt 10):334-340. PubMed ID: 34605437
[TBL] [Abstract][Full Text] [Related]
2. Structures of human peptidylarginine deiminase type III provide insights into substrate recognition and inhibitor design.
Funabashi K; Sawata M; Nagai A; Akimoto M; Mashimo R; Takahara H; Kizawa K; Thompson PR; Ite K; Kitanishi K; Unno M
Arch Biochem Biophys; 2021 Sep; 708():108911. PubMed ID: 33971157
[TBL] [Abstract][Full Text] [Related]
3. Monomeric Form of Peptidylarginine Deiminase Type I Revealed by X-ray Crystallography and Small-Angle X-ray Scattering.
Saijo S; Nagai A; Kinjo S; Mashimo R; Akimoto M; Kizawa K; Yabe-Wada T; Shimizu N; Takahara H; Unno M
J Mol Biol; 2016 Jul; 428(15):3058-73. PubMed ID: 27393304
[TBL] [Abstract][Full Text] [Related]
4. Human peptidylarginine deiminase type III: molecular cloning and nucleotide sequence of the cDNA, properties of the recombinant enzyme, and immunohistochemical localization in human skin.
Kanno T; Kawada A; Yamanouchi J; Yosida-Noro C; Yoshiki A; Shiraiwa M; Kusakabe M; Manabe M; Tezuka T; Takahara H
J Invest Dermatol; 2000 Nov; 115(5):813-23. PubMed ID: 11069618
[TBL] [Abstract][Full Text] [Related]
5. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274
[TBL] [Abstract][Full Text] [Related]
6. Crystallization and preliminary X-ray crystallographic analysis of human peptidylarginine deiminase type III.
Unno M; Kizawa K; Ishihara M; Takahara H
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Jun; 68(Pt 6):668-70. PubMed ID: 22684066
[TBL] [Abstract][Full Text] [Related]
7. Three isozymes of peptidylarginine deiminase in the chicken: molecular cloning, characterization, and tissue distribution.
Shimizu A; Handa K; Honda T; Abe N; Kojima T; Takahara H
Comp Biochem Physiol B Biochem Mol Biol; 2014 Jan; 167():65-73. PubMed ID: 24161753
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of human peptidylarginine deiminase type VI (PAD6) provides insights into its inactivity.
Ranaivoson FM; Bande R; Cardaun I; De Riso A; Gärtner A; Loke P; Reinisch C; Vogirala P; Beaumont E
IUCrJ; 2024 May; 11(Pt 3):395-404. PubMed ID: 38656308
[TBL] [Abstract][Full Text] [Related]
9. Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination.
Mondal S; Thompson PR
Acc Chem Res; 2019 Mar; 52(3):818-832. PubMed ID: 30844238
[TBL] [Abstract][Full Text] [Related]
10. Association of cross-reactive antibodies targeting peptidyl-arginine deiminase 3 and 4 with rheumatoid arthritis-associated interstitial lung disease.
Giles JT; Darrah E; Danoff S; Johnson C; Andrade F; Rosen A; Bathon JM
PLoS One; 2014; 9(6):e98794. PubMed ID: 24901704
[TBL] [Abstract][Full Text] [Related]
11. Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro.
Raijmakers R; Zendman AJ; Egberts WV; Vossenaar ER; Raats J; Soede-Huijbregts C; Rutjes FP; van Veelen PA; Drijfhout JW; Pruijn GJ
J Mol Biol; 2007 Apr; 367(4):1118-29. PubMed ID: 17303166
[TBL] [Abstract][Full Text] [Related]
12. Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3.
Knuckley B; Causey CP; Jones JE; Bhatia M; Dreyton CJ; Osborne TC; Takahara H; Thompson PR
Biochemistry; 2010 Jun; 49(23):4852-63. PubMed ID: 20469888
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of peptidyl-arginine deiminase (PAD): can it control multiple inflammatory disorders as a promising therapeutic strategy?
Padhy DS; Palit P; Ikbal AMA; Das N; Roy DK; Banerjee S
Inflammopharmacology; 2023 Apr; 31(2):731-744. PubMed ID: 36806957
[TBL] [Abstract][Full Text] [Related]
14. Deimination in epidermal barrier and hair formation.
Méchin MC; Simon M
Philos Trans R Soc Lond B Biol Sci; 2023 Nov; 378(1890):20220245. PubMed ID: 37778378
[TBL] [Abstract][Full Text] [Related]
15. Specific citrullination causes assembly of a globular S100A3 homotetramer: a putative Ca2+ modulator matures human hair cuticle.
Kizawa K; Takahara H; Troxler H; Kleinert P; Mochida U; Heizmann CW
J Biol Chem; 2008 Feb; 283(8):5004-13. PubMed ID: 18083705
[TBL] [Abstract][Full Text] [Related]
16. Modulation of calcium-induced cell death in human neural stem cells by the novel peptidylarginine deiminase-AIF pathway.
U KP; Subramanian V; Nicholas AP; Thompson PR; Ferretti P
Biochim Biophys Acta; 2014 Jun; 1843(6):1162-71. PubMed ID: 24607566
[TBL] [Abstract][Full Text] [Related]
17. Applicability of Small-Molecule Inhibitors in the Study of Peptidyl Arginine Deiminase 2 (PAD2) and PAD4.
Martín Monreal MT; Rebak AS; Massarenti L; Mondal S; Šenolt L; Ødum N; Nielsen ML; Thompson PR; Nielsen CH; Damgaard D
Front Immunol; 2021; 12():716250. PubMed ID: 34737738
[TBL] [Abstract][Full Text] [Related]
18. Peptidylarginine Deiminase Isozyme-Specific PAD2, PAD3 and PAD4 Inhibitors Differentially Modulate Extracellular Vesicle Signatures and Cell Invasion in Two Glioblastoma Multiforme Cell Lines.
Uysal-Onganer P; MacLatchy A; Mahmoud R; Kraev I; Thompson PR; Inal JM; Lange S
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098295
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Biological Evaluation of an Indazole-Based Selective Protein Arginine Deiminase 4 (PAD4) Inhibitor.
Tjin CC; Wissner RF; Jamali H; Schepartz A; Ellman JA
ACS Med Chem Lett; 2018 Oct; 9(10):1013-1018. PubMed ID: 30344909
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4.
Arita K; Shimizu T; Hashimoto H; Hidaka Y; Yamada M; Sato M
Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5291-6. PubMed ID: 16567635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
